First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
- PMID: 37843384
- PMCID: PMC10687595
- DOI: 10.1093/jpids/piad088
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
Abstract
Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared with reference values for adults, supporting studies on increased doses of first-line TB drugs in infants.
Keywords: HIV; HRZE; Tuberculosis; infants; pharmacokinetics.
© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society.
Figures

References
-
- UNAIDS. UNAIDS Data 2022. Geneva, Switzerland: Geneva Joint United Nations Programme on HIV/AIDS; 2022.
-
- Marais BJ, Gie RP, Schaaf HS, et al. . The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8:392–402. - PubMed
-
- Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE.. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349:1157–67. - PubMed
-
- Kwara A, Yang H, Martyn-Dickens C, et al. . Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children. Int J Tuberc Lung Dis 2023; 27:401–7. - PubMed